VOYA Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.42M | Buy |
|
|||||
|
2025
Q1 | $7.12M | Buy |
|
|||||
|
2024
Q4 | $5.76M | Sell |
|
|||||
|
2024
Q3 | $6.35M | Buy |
|
|||||
|
2024
Q2 | $7.37M | Buy |
|
|||||
|
2024
Q1 | $7.42M | Sell |
|
|||||
|
2023
Q4 | $8.94M | Buy |
|
|||||
|
2023
Q3 | $7.8M | Sell |
|
|||||
|
2023
Q2 | $7.67M | Buy |
|
|||||
|
2023
Q1 | $7.9M | Buy |
|
|||||
|
2022
Q4 | $7.94M | Buy |
|
|||||
|
2022
Q3 | $6.19M | Buy |
|
|||||
|
2022
Q2 | $2.02M | Sell |
|
|||||
|
2022
Q1 | $1.97M | Hold |
|
|||||
|
2021
Q4 | $2.26M | Sell |
|
|||||
|
2021
Q3 | $2.24M | Sell |
|
|||||
|
2021
Q2 | $2.43M | Sell |
|
|||||
|
2021
Q1 | $4.28M | Sell |
|
|||||
|
2020
Q4 | $55.5M | Buy |
|
|||||
|
2020
Q3 | $46M | Sell |
|
|||||
|
2020
Q2 | $154M | Buy |
|
|||||
|
2020
Q1 | $72.2M | Sell |
|
|||||
|
2019
Q4 | $80.8M | Buy |
|
|||||
|
2019
Q3 | $53.7M | Sell |
|
|||||
|
2019
Q2 | $70.6M | Buy |
|
|||||
|
2019
Q1 | $71.4M | Sell |
|
|||||
|
2018
Q4 | $70.9M | Buy |
|
|||||
|
2018
Q3 | $36.5M | Buy |
|
|||||
|
2018
Q2 | $32M | Sell |
|
|||||
|
2018
Q1 | $28.9M | Sell |
|
|||||
|
2017
Q4 | $67.4M | Sell |
|
|||||
|
2017
Q3 | $74.1M | Buy |
|
|||||
|
2017
Q2 | $63.1M | Buy |
|
|||||
|
2017
Q1 | $57.2M | Buy |
|
|||||
|
2016
Q4 | $49.9M | Sell |
|
|||||
|
2016
Q3 | $56.9K | Sell |
|
|||||
|
2016
Q2 | $48.7M | Buy |
|
|||||
|
2016
Q1 | $39.5M | Sell |
|
|||||
|
2015
Q4 | $50.9M | Sell |
|
|||||
|
2015
Q3 | $63.2M | Sell |
|
|||||
|
2015
Q2 | $85.7M | Sell |
|
|||||
|
2015
Q1 | $79.7M | Buy |
|
|||||
|
2014
Q4 | $6.33M | Sell |
|
|||||
|
2014
Q3 | $5.32M | Sell |
|
|||||
|
2014
Q2 | $4.63M | Sell |
|
|||||
|
2014
Q1 | $5.7M | Buy |
|
|||||
|
2013
Q4 | $5.87M | Sell |
|
|||||
|
2013
Q3 | $6.17M | Sell |
|
|||||
|
2013
Q2 | $4.79M | Buy |
|